论文部分内容阅读
目的观察早期使用银杏达莫注射液治疗出血性脑梗死的临床疗效。方法将2006年1月至2010年10月收治的60例出血性脑梗死患者随机分为治疗组30例和对照组30例,两组均采用常规中性治疗方法,治疗组加用银杏达莫注射液。结果治疗组愈显率76.7%,对照组43.3%,两组比较有统计学意义(P<0.05);神经功能缺损评分较对照组下降明显(P<0.01),且无不良反应。结论银杏达莫治疗出血性脑梗死可降低病残程度和提高治疗效果。
Objective To observe the clinical efficacy of the early use of gingko Damo injection in the treatment of hemorrhagic cerebral infarction. Methods Sixty patients with hemorrhagic cerebral infarction admitted from January 2006 to October 2010 were randomly divided into treatment group (n = 30) and control group (n = 30). Both groups were treated by conventional neutral treatment. Injection. Results The cure rate was 76.7% in the treatment group and 43.3% in the control group, the two groups were statistically significant (P <0.05). The score of neurological deficit was significantly lower than that of the control group (P <0.01), and no adverse reactions were found. Conclusion Ginkgo biloba treatment of hemorrhagic cerebral infarction can reduce the degree of disability and improve the therapeutic effect.